GENOMICS SHARED RESOURCE (GSR) ABSTRACT Xinmin Li, PhD (ZY), Director, and Ling Dong, PhD, Co-Director, lead the UCLA Jonsson Comprehensive Cancer Center (JCCC) Genomics Shared Resource (GSR). The GSR provides JCCC investigators with state- of-the-art genomics technologies, comprehensive services, specialized expertise, and a wide range of training opportunities, to enable transformative research that is cost-effective and timely. The facility is a high-throughput and fully automated genomics core located in the Center for Health Sciences (CHS) building, near JCCC investigator laboratories. The GSR occupies 2,568 sf. of laboratory and administrative space and is equipped with all major state-of-the-art instruments for genomics analyses including a range of next generation sequencers, microarray platforms, and a single cell 10X Genomics Chromium Controller. Eleven staff members total, including one faculty member, Li, and eight PhD scientists, operate the GSR, providing 76 years of combined genomics experience. The GSR has a broad user base. From 2013 ? 2018, the GSR supported 76 unique JCCC investigators in 2,344 research projects from all six JCCC Research Programs. This represents 26% (36,274 JCCC experiments/ 140,087 total experiments) of total Shared Resource usage. Of these 76 JCCC investigators, 22% are peer- review funded. GSR support activities helped to enable 235 publications, of which 151 (64%) were in high-impact (IF ?10, or field leading) journals. In addition, the GSR supported numerous cancer research projects from cancer investigators at nine non-UCLA cancer centers and served numerous additional external investigators from >150 non-UCLA institutions. JCCC investigators benefited significantly from the large number of external users by enabling a 43% discount in pricing to JCCC member labs during the prior project period while maintaining quick turnaround times from a formal GSR policy that prioritizes JCCC investigators, followed by other UCLA investigators, over external users. The primary goals of the GSR is to provide JCCC investigators with access to state-of-the-art genomic capabilities and genomics training, provide planning assistance for multidisciplinary projects, and enable investigators to develop new applications using the most advanced technologies by continual core upgrades. Through these goals and its service activities, the GSR accelerates the pace of cancer discoveries that support the translational pipeline for implementation in clinical settings.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016042-44
Application #
9936715
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Tsang, Eric J; Wu, Benjamin; Zuk, Patricia (2018) MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro. Connect Tissue Res 59:129-146
Waters, Lynnea R; Ahsan, Fasih M; Wolf, Dane M et al. (2018) Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling. iScience 5:99-109
Van Dyk, Kathleen; Bower, Julienne E; Crespi, Catherine M et al. (2018) Cognitive function following breast cancer treatment and associations with concurrent symptoms. NPJ Breast Cancer 4:25
Robinett, Ryan A; Guan, Ning; Lux, Anja et al. (2018) Dissecting Fc?R Regulation through a Multivalent Binding Model. Cell Syst 7:41-48.e5
Chin, Chee Jia; Li, Suwen; Corselli, Mirko et al. (2018) Transcriptionally and Functionally Distinct Mesenchymal Subpopulations Are Generated from Human Pluripotent Stem Cells. Stem Cell Reports 10:436-446
Alban, Tyler J; Alvarado, Alvaro G; Sorensen, Mia D et al. (2018) Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis. JCI Insight 3:
Yang, Qing; Fung, Wing K; Li, Gang (2018) Sample size determination for jointly testing a cause-specific hazard and the all-cause hazard in the presence of competing risks. Stat Med 37:1389-1401
Seo, Jai Woong; Tavaré, Richard; Mahakian, Lisa M et al. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clin Cancer Res 24:4976-4987
Ribas, Antoni; Wolchok, Jedd D (2018) Cancer immunotherapy using checkpoint blockade. Science 359:1350-1355
Wang, Hong; Chen, Xiaolin; Li, Gang (2018) Survival Forests with R-Squared Splitting Rules. J Comput Biol 25:388-395

Showing the most recent 10 out of 767 publications